217 related articles for article (PubMed ID: 21403438)
1. [Helicobacter pylori infection and liver diseases].
Takuma Y
Gan To Kagaku Ryoho; 2011 Mar; 38(3):362-4. PubMed ID: 21403438
[TBL] [Abstract][Full Text] [Related]
2. [Helicobacter pylori and hepatobiliary diseases].
Messini F
Clin Ter; 2003; 154(1):55-6. PubMed ID: 12854285
[TBL] [Abstract][Full Text] [Related]
3. [Prevalence of Helicobacter pylori in liver cirrhosis complicated with hepatic encephalopathy].
Săndulache L; Stanciu C
Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1056-60. PubMed ID: 20191873
[TBL] [Abstract][Full Text] [Related]
4. [Extra-gastrointestinal tract diseases and Helicobacter pylori infection].
Banić M; Buljevac M; Kujundzić M; Jelić D; Dominis M; Colić-Cvrlje V; Kardum D; Katicić M
Lijec Vjesn; 2002 Sep; 124 Suppl 1():63-8. PubMed ID: 12592821
[TBL] [Abstract][Full Text] [Related]
5. [Prevalence and role of Helicobacter pylori infection in some gastroduodenal and hepatic complications in cirrhotic patients].
Săndulache L; Stanciu C
Rev Med Chir Soc Med Nat Iasi; 2008; 112(4):890-5. PubMed ID: 20209758
[TBL] [Abstract][Full Text] [Related]
6. Analysis of risk factors for chronic hepatic encephalopathy: the role of Helicobacter pylori infection.
Dasani BM; Sigal SH; Lieber CS
Am J Gastroenterol; 1998 May; 93(5):726-31. PubMed ID: 9625117
[TBL] [Abstract][Full Text] [Related]
7. Identification of Helicobacter species by 16S rDNA PCR and sequence analysis in human liver samples from patients with various etiologies of benign liver diseases.
Cindoruk M; Cirak MY; Unal S; Karakan T; Erkan G; Engin D; Dumlu S; Turet S
Eur J Gastroenterol Hepatol; 2008 Jan; 20(1):33-6. PubMed ID: 18090988
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori and hepatic encephalopathy.
Duseja A; Sachdev A; Dhiman RK; Chawla YK
Indian J Gastroenterol; 2003 Dec; 22 Suppl 2():S31-2. PubMed ID: 15025251
[TBL] [Abstract][Full Text] [Related]
9. [Study of correlation between Helicobacter pylori infection and hyperammonemia and hepatic encephalopathy in cirrhotic patients].
Yang CS; Cao SY; He XJ; Wang YX; Zhang YL
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):422-4. PubMed ID: 17631712
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori and gastroesophageal reflux disease: friends or foes?
Gisbert JP; Pajares JM; Losa C
Hepatogastroenterology; 1999; 46(26):1023-9. PubMed ID: 10370661
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori and the liver: any relationship?
Farinati F; De Bona M; Floreani A; Foschia F; Rugge M
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):124-8. PubMed ID: 9615280
[TBL] [Abstract][Full Text] [Related]
12. The role of Helicobacter spp. in the pathogenesis of primary biliary cirrhosis and primary sclerosing cholangitis.
Boomkens SY; de Rave S; Pot RG; Egberink HF; Penning LC; Rothuizen J; Zondervan PE; Kusters JG
FEMS Immunol Med Microbiol; 2005 May; 44(2):221-5. PubMed ID: 15866219
[TBL] [Abstract][Full Text] [Related]
13. [Helicobacter pylori infection: extragastric effects and diseases (a critical analysis)].
Tsimmerman IaS
Klin Med (Mosk); 2006; 84(4):63-7. PubMed ID: 16755861
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
15. [Effects of Helicobacter pylori eradication on gastritis in patients with chronic liver disease].
Ikezawa K
Nihon Rinsho; 2005 Nov; 63 Suppl 11():482-5. PubMed ID: 16363584
[No Abstract] [Full Text] [Related]
16. Does H. pylori eradication therapy benefit patients with hepatic encephalopathy?: systematic review.
Schulz C; Schütte K; Malfertheiner P
J Clin Gastroenterol; 2014 Jul; 48(6):491-9. PubMed ID: 24583758
[TBL] [Abstract][Full Text] [Related]
17. Serum antibodies to enterohepatic Helicobacter spp. in patients with chronic liver diseases and in a population with high prevalence of H. pylori infection.
Vorobjova T; Nilsson I; Terjajev S; Granholm M; Lyyra M; Porkka T; Prükk T; Salupere R; Maaroos HI; Wadström T; Uibo R
Dig Liver Dis; 2006 Mar; 38(3):171-6. PubMed ID: 16464652
[TBL] [Abstract][Full Text] [Related]
18. Primary biliary cirrhosis, similar to that in human beings, in a male C57BL/6 mouse infected with Helicobacter pylori.
Goo MJ; Ki MR; Lee HR; Hong IH; Park JK; Yang HJ; Yuan DW; Hwang OK; Do SH; Yoo SE; Jeong KS
Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):1045-8. PubMed ID: 18787477
[TBL] [Abstract][Full Text] [Related]
19. Chronic atrophic gastritis and Helicobacter pylori infection in primary biliary cirrhosis: a cross-sectional study with matching.
Floreani A; Biagini MR; Zappalà F; Farinati F; Plebani M; Rugge M; Surrenti C; Naccarato R
Ital J Gastroenterol Hepatol; 1997 Feb; 29(1):13-7. PubMed ID: 9265572
[TBL] [Abstract][Full Text] [Related]
20. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen.
Chan FK; Chung SC; Suen BY; Lee YT; Leung WK; Leung VK; Wu JC; Lau JY; Hui Y; Lai MS; Chan HL; Sung JJ
N Engl J Med; 2001 Mar; 344(13):967-73. PubMed ID: 11274623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
